In a partnership between Sight Savers America and the Alabama Institute for Deaf and Blind in Mobile, 15 people who have visual impairments can see more clearly
FRANKFURT (Reuters) -Bayer said on Friday that the European Medicines Agency recommended approval of a higher dose version of eye drug Eylea for treatment of a leading cause of blindness among the elderly, stepping up competition with Roche. The European Commission, which has the final word on drug approvals in the EU, typically follows the recommendations issued by the EMA. A go-ahead would mean that Eylea, an injection in the eye also known as aflibercept and jointly developed with Regeneron, can be given in doses of 8 milligrams instead of the usual 2 milligrams, allowing for longer intervals between injections.
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2023 /PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, presents latest data of two ophthalmic bispecific antibodies at the American Academy of Ophthalmology (AAO) 2023 Annual Meeting, including a.
Trauma News healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.